Benlysta



Indications and Reactions:

Role Indications Reactions
Primary
Systemic Lupus Erythematosus 83.7%
Product Used For Unknown Indication 10.9%
Premedication 1.2%
Pain 0.8%
Cutaneous Lupus Erythematosus 0.4%
Hypertension 0.4%
Anxiety 0.3%
Fibromyalgia 0.3%
Hypothyroidism 0.3%
Sle 0.3%
Migraine 0.2%
Type 2 Diabetes Mellitus 0.2%
Diabetes Mellitus 0.2%
Headache 0.2%
Osteoporosis 0.2%
Rash 0.2%
Sinusitis 0.2%
Arthritis 0.1%
Deep Vein Thrombosis 0.1%
Depression 0.1%
Nausea 10.1%
Systemic Lupus Erythematosus 9.5%
Vomiting 7.5%
Pyrexia 5.7%
Urticaria 5.5%
Weight Increased 5.5%
Pain In Extremity 5.2%
Rash 5.1%
Pruritus 4.8%
Diarrhoea 4.4%
Drug Ineffective 4.4%
Headache 4.4%
Urinary Tract Infection 4.3%
Fatigue 4.1%
Pain 3.7%
Weight Decreased 3.7%
Insomnia 3.5%
Sinusitis 3.2%
Migraine 2.8%
Malaise 2.5%
Secondary
Product Used For Unknown Indication 50.0%
Systemic Lupus Erythematosus 43.8%
Pain 3.8%
Anxiety 0.8%
Skin Lesion 0.8%
Sle 0.8%
Fatigue 10.8%
Procedural Pain 10.8%
Deep Vein Thrombosis 8.1%
Dizziness 8.1%
Vomiting 8.1%
Back Pain 5.4%
Headache 5.4%
Migraine 5.4%
Pain 5.4%
Urosepsis 5.4%
Auricular Swelling 2.7%
Cardiac Arrest 2.7%
Diarrhoea 2.7%
Escherichia Bacteraemia 2.7%
Escherichia Infection 2.7%
Eye Infection 2.7%
Feeling Abnormal 2.7%
General Physical Health Deterioration 2.7%
Haematocrit Decreased 2.7%
Herpes Zoster 2.7%
Concomitant
Product Used For Unknown Indication 38.6%
Systemic Lupus Erythematosus 34.1%
Drug Use For Unknown Indication 13.6%
Rheumatoid Arthritis 9.1%
Lupus Syndrome 2.3%
Osteoporosis Postmenopausal 2.3%
Ovarian Abscess 12.5%
Shoulder Arthroplasty 12.5%
Aspergillosis 6.3%
Balance Disorder 6.3%
Dyspepsia 6.3%
Erythema 6.3%
Headache 6.3%
Hypersensitivity 6.3%
Mood Altered 6.3%
Oral Disorder 6.3%
Pain 6.3%
Pneumonia 6.3%
Pruritus Generalised 6.3%
Wrist Fracture 6.3%